Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.
By: Catalina Vasquez By: Catalina Vasquez Stay Informed
To stay up to date on all the latest news and publications, subscribe to our newsletter!
Recent Posts
Thank you for attending the APCaRI Fall Symposium 2022!
Posted on Nov 22 22 at 2:28pm
14th Annual APCaRI Fall Symposium 2022
Posted on Nov 14 22 at 9:31am
Recognizing 10 years of philanthropy for prostate cancer research
Posted on Oct 13 22 at 11:54pm